Erratum to: Heregulin-1ß and HER3 in hepatocellular carcinoma: status and regulation by insulin
نویسندگان
چکیده
Author details Sorbonne Universités, UPMC Univ Paris 06, INSERM, Saint-Antoine Research Center, 34 rue Crozatier, F-75012 Paris, France. Department of Hepatology, AP-HP, Saint-Antoine Hospital, F-75012 Paris, France. Department of Hepatology, AP-HP, Pitié-Salpétrière Hospital, F-75013 Paris, France. Department of Pathology, AP-HP, Saint-Antoine Hospital, F-75012 Paris, France. Histomorphology Platform, UMS 30 Lumic, F-75012 Paris, France. Human HepCell, Saint-Antoine Hospital, F-75012 Paris, France. Department of Hepatobiliary Surgery and Liver Transplantation, AP-HP, Pitié-Salpétrière Hospital, F-75013 Paris, France.
منابع مشابه
Heregulin-1ß and HER3 in hepatocellular carcinoma: status and regulation by insulin
BACKGROUND The heregulin-1ß/HER3-driven pathway is implicated in several epithelial malignancies and its blockade is currently undergoing clinical investigation. Paradoxically, the status and the regulation of this pathway is poorly known in hepatocellular carcinoma (HCC). METHODS Using 85 HCC obtained after tumour resection, heregulin-1ß and HER3 expression was evaluated by real-time RT-PCR,...
متن کاملHeregulin and HER3 are prognostic biomarkers in oropharyngeal squamous cell carcinoma.
BACKGROUND Although heregulin and human epidermal growth factor receptor 3 (HER3) are frequently expressed at high levels in patients with head and neck cancer, their prognostic value remains unclear. The authors explored the prognostic significance of heregulin/HER3 expression in patients with oropharyngeal squamous cell carcinoma (OPSCC), taking into account other HER family members as well a...
متن کاملmiR-26b enhances radiosensitivity of hepatocellular carcinoma cells by targeting EphA2
Objective(s): Although low-dose radiotherapy (RT) that involves low collateral damage is more suitable for hepatocellular carcinoma (HCC) than traditional high-dose RT, but to achieve satisfactory therapeutic effect with low-dose RT, it is necessary to sensitize HCC cells to irradiation. This study was aimed to determine whether radiosensitivity of HCC cells can be enhanced using miR-26b by tar...
متن کاملHeregulin-expressing HER2-positive breast and gastric cancer exhibited heterogeneous susceptibility to the anti-HER2 agents lapatinib, trastuzumab and T-DM1
BACKGROUND Overexpression of heregulin, a HER3 ligand, is one mechanism that confers resistance to the anti-HER2 agents trastuzumab and lapatinib. We investigated the impact of heregulin expression on the efficacy of HER2-targeted therapeutic agents, including trastuzumab, trastuzumab emtansine (T-DM1) and lapatinib, in vitro and in vivo and evaluated the heregulin messenger RNA (mRNA) levels i...
متن کاملThe anti-HER3 antibody patritumab abrogates cetuximab resistance mediated by heregulin in colorectal cancer cells
We previously showed that tumor-derived heregulin, a ligand for HER3, is associated with both de novo and acquired resistance to cetuximab. We have now examined whether patritumab, a novel neutralizing monoclonal antibody to HER3, is able to overcome such resistance. Human colorectal cancer (DiFi) cells that are highly sensitive to cetuximab were engineered to stably express heregulin by retrov...
متن کامل